全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Transarterial injection of H101 in combination with chemoembolization overcomes recurrent hepatocellular carcinoma

DOI: 10.3748/wjg.v17.i18.2353

Keywords: Hepatocellular carcinoma , H101 , Transcatheter arterial chemoembolization , Therapy

Full-Text   Cite this paper   Add to My Lib

Abstract:

Transcatheter arterial chemoembolization (TACE) has become the standard treatment modality for unresectable hepatocellular carcinoma (HCC). Nonetheless, the clinical outcomes in patients with unresectable HCC are often unsatisfactory, especially in those with recurrent HCC. H101, an E1B gene deleted adenovirus, is known to have a significant antitumor activity. In addition, local injection of H101 can enhance the effect of antitumor therapies (chemotherapy and radiotherapy). Transarterial H101 gene injection in combination with TACE may help to control refractory and recurrent HCC. In this study, we report a 55-year-old patient with recurrent HCC which was treated with transarterial injection of H101 in combination with TACE, leading to a good clinical prognosis of the patient.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133